Alzheimer's disease (AD) presently occupies the topmost position among the most diagnosed neurodegenerative diseases worldwide, with the number of affected people forecasted to reach 100 million by 2050. According to the latest statistics, nearly 44 million people in the world suffer from AD or related dementia, with only one in four being diagnosed with the disease. Learn more: In Vitro Models in AD

Creative Biolabs offers the most advanced and comprehensive iPSC services for our customers all over the world. With years of experience, scientists at Creative Biolabs now are able to generate the neuronal cells via our iPSC differentiation technology. Learn more: neural stem cells

Through the intelligent delivery of drugs, liposomes provide a solid foundation for the sustainable development of various commercial products for the treatment of medical diseases. It has been proven that sterically stabilized liposomes can extend the circulation time of small molecule drugs by reducing the clearance of the reticuloendothelial system (RES).Learn more: Liposome encapsulated small molecule